Ionis Pharmaceuticals Inc
IONS- 交易所
- Nasdaq
- 產業
- Pharmaceutical Preparations
- SEC CIK
- 0000874015
近 90 天,Ionis Pharmaceuticals Inc 內部人申報 1 筆公開市場買進、2 筆賣出;2026 年第 3 季末有 464 家機構在 13F 申報持有,市值合計 $76.6 億;大師中只有方舟投資持有。
持有 IONS 5% 以上的大股東
最新一份 Schedule 13D 或 13G 申報持有 Ionis Pharmaceuticals Inc 5% 以上的持有人,依持股比例由大到小;變化是跟這位持有人的上一份申報比。
| 持有人 | 最新表單 | 持股 | 變化 | 首次申報 | 最新申報 | 原文 |
|---|---|---|---|---|---|---|
| Capital World Investors | 13G/A | 12.80%股數 2,119 萬 | +1.70 個百分點原本 11.10% | 2025/2/133 份 | 2026/5/14 | SEC |
| BlackRock, Inc. | 13G/A | 5.70%股數 906.7 萬 | – | 2025/4/171 份 | 2025/4/17 | SEC |
| Vanguard Capital Management LLC | 13G | 5.05%股數 834.5 萬 | 新申報 | 2026/4/301 份 | 2026/4/30 | SEC |
持股是每位持有人最新一份申報的數字。最後一份是舊格式(2024 年 12 月 18 日以前)的持有人沒有持股比例紀錄,不列在這裡;公司被收購或下市之後,持有人通常就不再申報。
13D 與 13G 申報
Ionis Pharmaceuticals Inc 的 40 份 Schedule 13D、13G 申報,由新到舊,包括沒有持股比例的舊格式申報。
| 申報時間(美東) | 申報人 | 表單 | 持股 | 變化 | 事件日 | 原文 |
|---|---|---|---|---|---|---|
| 2026/5/1510:06 ET | T. Rowe Price Investment Management, Inc. | 13G/A | 3.70%股數 615.9 萬 | −1.90 個百分點原本 5.60%低於 5% | 2026/3/31 | SEC |
| 2026/5/1413:55 ET | Capital World Investors | 13G/A | 12.80%股數 2,119 萬 | +1.70 個百分點原本 11.10% | 2026/3/31 | SEC |
| 2026/4/3011:07 ET | Vanguard Capital Management LLC | 13G | 5.05%股數 834.5 萬 | 新申報 | 2026/3/31 | SEC |
| 2026/3/2709:52 ET | Vanguard Group Inc | 13G/A | 0.00%股數 0 | −10.43 個百分點原本 10.43%低於 5% | 2026/3/13 | SEC |
| 2026/2/1710:28 ET | T. Rowe Price Investment Management, Inc. | 13G/A | 5.60%股數 910.8 萬 | −2.70 個百分點原本 8.30% | 2025/12/31 | SEC |
| 2026/1/719:48 ET | Capital World Investors | 13G/A | 11.10%股數 1,796 萬 | +3.80 個百分點原本 7.30% | 2025/12/31 | SEC |
| 2025/11/1412:18 ET | T. Rowe Price Investment Management, Inc. | 13G/A | 8.30%股數 1,316 萬 | −1.70 個百分點原本 10.00% | 2025/9/30 | SEC |
| 2025/8/1210:34 ET | Wellington Management Group LLP等 3 位 | 13G/A | 4.30%股數 688.0 萬 | –低於 5% | 2025/6/30 | SEC |
| 2025/4/1709:35 ET | BlackRock, Inc. | 13G/A | 5.70%股數 906.7 萬 | – | 2025/3/31 | SEC |
| 2025/2/1316:53 ET | Capital World Investors | 13G | 7.30%股數 1,147 萬 | 新申報 | 2024/12/31 | SEC |
| 2025/2/711:55 ET | T. Rowe Price Investment Management, Inc. | 13G/A | 10.00%股數 1,585 萬 | – | 2025/1/31 | SEC |
| 2025/1/811:29 ET | Vanguard Group Inc | 13G/A | 10.43%股數 1,647 萬 | – | 2024/12/31 | SEC |
| 2024/11/14 | T. Rowe Price Investment Management, Inc. | 13G/A舊制 | – | – | – | SEC |
| 2024/11/14 | BB Biotech AG | 13G/A舊制 | – | – | – | SEC |
| 2024/11/8 | Wellington Management Group LLP | 13G舊制 | – | 新申報 | – | SEC |
| 2024/2/14 | T. Rowe Price Investment Management, Inc. | 13G舊制 | – | – | – | SEC |
| 2024/2/13 | BB Biotech AG | 13G/A舊制 | – | – | – | SEC |
| 2024/2/13 | Vanguard Group Inc | 13G/A舊制 | – | – | – | SEC |
| 2024/2/9 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2024/1/2616:25 ET | BlackRock Inc. | 13G/A舊制 | – | – | – | SEC |
| 2023/6/9 | Vanguard Group Inc | 13G/A舊制 | – | – | – | SEC |
| 2023/2/14 | T. Rowe Price Investment Management, Inc. | 13G舊制 | – | 新申報 | – | SEC |
| 2023/2/14 | BB Biotech AG | 13G/A舊制 | – | – | – | SEC |
| 2023/2/9 | Vanguard Group Inc | 13G/A舊制 | – | – | – | SEC |
| 2023/2/9 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2023/1/3117:52 ET | BlackRock Inc. | 13G/A舊制 | – | – | – | SEC |
| 2022/8/10 | Price T Rowe Associates Inc | 13G/A舊制 | – | – | – | SEC |
| 2022/4/11 | Price T Rowe Associates Inc | 13G/A舊制 | – | – | – | SEC |
| 2022/2/14 | Price T Rowe Associates Inc | 13G/A舊制 | – | – | – | SEC |
| 2022/2/11 | BB Biotech AG | 13G/A舊制 | – | – | – | SEC |
| 2022/2/10 | Vanguard Group Inc | 13G/A舊制 | – | – | – | SEC |
| 2022/2/9 | ARK Investment Management LLC大師方舟投資 | 13G舊制 | – | 新申報 | – | SEC |
| 2022/2/9 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2022/2/117:08 ET | BlackRock Inc. | 13G舊制 | – | – | – | SEC |
| 2021/2/16 | Price T Rowe Associates Inc | 13G舊制 | – | 新申報 | – | SEC |
| 2021/2/12 | BB Biotech AG | 13G/A舊制 | – | – | – | SEC |
| 2021/2/10 | Vanguard Group Inc | 13G/A舊制 | – | – | – | SEC |
| 2021/2/9 | Clearbridge Investments, LLC | 13G/A舊制 | – | – | – | SEC |
| 2021/2/8 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2021/2/507:51 ET | BlackRock Inc. | 13G/A舊制 | – | – | – | SEC |
Form 144:內部人預計賣出
高階主管、董事與其他關係人預計賣出 Ionis Pharmaceuticals Inc 股票的 188 份通知,由新到舊。
| 申報時間(美東) | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|
| 2026/10/1617:16 ET | Devers Shannon L.高階主管 | 1,357 | $5.97 萬 | 2026/10/16 | Morgan Stanley Smith Barney | SEC |
| 2026/7/716:33 ET | Diaz Allene M.董事 | 1.01 萬 | $86.4 萬 | 2026/7/710b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/7/716:30 ET | Kordasiewicz Holly B.高階主管 | 1,287 | $10.8 萬 | 2026/7/710b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/7/716:28 ET | Bennett C Frank高階主管 | 6.74 萬 | $572.5 萬 | 2026/7/710b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/7/117:29 ET | Klein Joseph III董事 | 1.15 萬 | $91.0 萬 | 2026/7/110b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/6/2617:48 ET | Baroldi Mariana內部人的家屬 | 5,635 | $45.2 萬 | 2026/6/2610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/6/2617:47 ET | O'Neil Patrick R.高階主管 | 3,069 | $24.6 萬 | 2026/6/2610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/6/2617:43 ET | Schneider Eugene高階主管 | 4.79 萬 | $388.1 萬 | 2026/6/2610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/6/2518:53 ET | Swayze Eric高階主管 | 1.06 萬 | $83.9 萬 | 2026/6/2510b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/6/1510:17 ET | Berthelsen Spencer R董事 | 8,000 | $58.8 萬 | 2026/6/1510b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/6/1216:29 ET | Kordasiewicz Holly B.高階主管 | 6.08 萬 | $446.6 萬 | 2026/6/1210b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/6/110:47 ET | Berthelsen Spencer R董事 | 8,000 | $60.5 萬 | 2026/6/110b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/5/1317:20 ET | Monia Brett P高階主管 | 10.0 萬 | $780.1 萬 | 2026/5/1310b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/5/418:05 ET | Loscalzo Joseph董事 | 5.43 萬 | $434.6 萬 | 2026/5/410b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/4/2816:12 ET | Baroldi Joseph高階主管 | 1,626 | $11.7 萬 | 2026/4/2810b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/4/1618:49 ET | Jenne Kyle高階主管 | 4,902 | $37.0 萬 | 2026/4/16 | Morgan Stanley Smith Barney | SEC |
| 2026/4/1618:47 ET | Birchler Brian高階主管 | 973 | $7.34 萬 | 2026/4/16 | Morgan Stanley Smith Barney | SEC |
| 2026/4/1618:45 ET | Baroldi Joseph高階主管 | 5,619 | $42.4 萬 | 2026/4/16 | Morgan Stanley Smith Barney | SEC |
| 2026/3/3117:28 ET | Diaz Allene M.董事 | 6.88 萬 | $547.0 萬 | 2026/3/310b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/3/2416:43 ET修正 | Schneider Eugene高階主管 | 5,812 | $41.2 萬 | 2026/3/1910b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/3/1616:32 ET | Hougen Elizabeth L高階主管 | 22.5 萬 | $1,628 萬 | 2026/3/1610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/3/1016:00 ET | Jenne Kyle董事 | 5.83 萬 | $440.2 萬 | 2026/3/1010b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/3/916:16 ET | O'Neil Patrick R.高階主管 | 1.32 萬 | $99.5 萬 | 2026/3/910b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/3/317:52 ET修正 | Bennett C Frank高階主管 | 8.51 萬 | $705.6 萬 | 2026/3/310b5-1 | Stifel Nicolaus & Company Inc | SEC |
| 2026/3/317:51 ET | Loscalzo Joseph董事 | 2.40 萬 | $192.0 萬 | 2026/3/310b5-1 | Stifel Nicolaus & Company Inc | SEC |
只列最新的 25 份。看 IONS 近 12 個月的全部通知